ILSI-Biomed Israel

Vaxil’s TB vaccine successfully passes first stage in animal studies

Nes-Ziona, 8th March, 2011. Vaxil Biotherapeutics Ltd., a clinical stage developer of innovative therapeutic vaccines announced today that MTbuVax, its vaccine against the lethal bacteria Mycobacterium Tuberculosis (MTb) has proven to manifest effective induction of immune response in mice. The studies demonstrated that mice vaccinated with MTbuVax produced potent CD4+ and CD8+ T-cell immunity that specifically proliferated in response to the MTbuVax vaccine. In addition, T-cells from vac...

Meet the Speakers: A Seminar about Vaccines in ILSI-BioMed 2010 Week

How will the panel of vaccine experts handle the recent developments in vaccine situations, such as Wakefield's article rennouncement by The Lancet, or the Swine Influenza vaccine? Greetings, dear readers! I'm happy to present a new section of this blog, termed Meet the Speakers. Every week, we'll introduce another of the lecturers and panelists in the up-and-coming ILSI-BioMed 2010 week. I hope it makes for an interesting reading! The last year, as well as the current one, has seen so...

Of Aging and the Universal Flu Vaccine

Two interesting headlines in Calcalist: in five years we'll get to know our approximated life expectency, and if everything goes alright, we'll have a universal Flu Vaccine  to boot. There’ve been two interesting articles in Calcalist (the Israeli Economist), lately. I really recommend reading this paper, as it has some quality articles appearing every few days. The first deals with the aging world, which is a topic that has vast ramifications on the economy, society and healthcare, espec...

Cancer Vaccine on the Way?

Successful experiments on mice show promise for the development of a vaccine against cancer. We live in the era of the vaccines. It has been just a little over two hundred years since the first vaccine was invented against smallpox, and eventually eradicated the disease from the face of the earth. Since then, vaccines were devised against many kinds of diseases, which are almost nonexistent today. Now, a new type of vaccine is being developed, and may serve as the turning point of the wa...